Trial Profile
Atomoxetine and Cerebrovascular Outcomes in Adults.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Sep 2009
Price :
$35
*
At a glance
- Drugs Amphetamines (Primary) ; Atomoxetine; Methylphenidate; Mixed amfetamine salts
- Indications Attention-deficit hyperactivity disorder
- Focus Adverse reactions
- Sponsors Eli Lilly and Company
- 18 Sep 2009 New trial record